Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 3/20 | 0.46 |
| ▸ | NPY4R | P50391 | 6/20 | 0.46 |
| ▸ | CCKBR | P32239 | 2/20 | 0.45 |
| ▸ | NPY1R | P25929 | 3/20 | 0.45 |
| ▸ | NPY2R | P49146 | 2/20 | 0.45 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.45 |
| ▸ | CTSL | P07711 | 2/20 | 0.44 |
| ▸ | CTSS | P25774 | 3/20 | 0.44 |
| ▸ | CTSB | P07858 | 1/20 | 0.44 |
| ▸ | CTSK | P43235 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28639434 | 1.00 | REN (0.46) | RENNPY4RCCKBRNPY1RNPY2R | |
| SCHEMBL28652457 | 0.93 | CTSS (0.48) | NPY4RNPY1RNPY2RNPY5RCTSS | |
| SCHEMBL28652461 | 0.93 | CTSS (0.48) | NPY4RNPY1RNPY2RNPY5RCTSS | |
| SCHEMBL22117410 | 0.92 | REN (0.48) | RENNPY4RCCKBRNPY1RNPY2R | |
| SCHEMBL22117409 | 0.92 | REN (0.48) | RENNPY4RCCKBRNPY1RNPY2R | |
| SCHEMBL31679022 | 0.91 | CTSL (0.51) | RENNPY4RCCKBRNPY1RNPY2R | |
| SCHEMBL31679016 | 0.89 | KLK7 (0.50) | NPY4RCCKBRCTSLCTSS | |
| SCHEMBL28644135 | 0.86 | REN (0.59) | RENCCKBRCTSLCTSSCTSB | |
| SCHEMBL28644132 | 0.86 | REN (0.59) | RENCCKBRCTSLCTSSCTSB | |
| SCHEMBL22117421 | 0.85 | REN (0.54) | RENNPY4RCCKBRNPY1RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113544138-A | Mitochondrial targeting peptides | 隐形生物治疗公司 | 2021-10-22 | — | — | CN | disclosed |